InMed Pharmaceuticals Amends Deal With Mentari Therapeutics
() -- InMed Pharmaceuticals (INM) entered into an amendment to its definitive merger agreement for an all-stock transaction with Mentari Therapeutics and its subsidiaries that clarifies details of the deal, the company said Monday. The updated details include the sequencing of the acquisition, the impact of the pre-clo